Latest News about PRTA
Recent news which mentions PRTA
28 Stocks Moving In Wednesday's Mid-Day Session
January 12, 2022
From Benzinga
Mid-Morning Market Update: Markets Open Higher; US Inflation Rate Rises To 7% In December
January 12, 2022
From Benzinga
7 Best Drug Stocks to Buy for 2022 Without Covid Catalysts
December 07, 2021
From InvestorPlace
7 A-Rated Biotechs to Buy for the Long Run
December 03, 2021
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021
November 19, 2021
From Benzinga
7 A-Rated Healthcare Stocks to Buy for the Long Haul
November 01, 2021
From InvestorPlace
What 8 Analyst Ratings Have To Say About Prothena Corp
September 20, 2021
Tickers
PRTA
From Benzinga
With Prothena Up Over 500% This Year, Is It Too Late to Get in?
September 18, 2021
From Motley Fool
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
September 03, 2021
From Benzinga
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
September 01, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
August 27, 2021
From Benzinga
From MarketWatch
10 Biggest Price Target Changes For Monday
August 09, 2021
From Benzinga
Biogen: Does Aduhelm Make it the Next Dendreon?
July 30, 2021
From InvestorPlace
Why Is Novo Nordisk Buying a Rare-Disease Candidate?
July 24, 2021
From Motley Fool
Got $2,500? Check Out These 3 Alzheimer's Therapy Stocks
July 17, 2021
From Motley Fool
10 Biggest Price Target Changes For Tuesday
July 13, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.